Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression

Parkinson’s disease has long been considered a disorder that primarily affects the brain, as it is defined by the dopaminergic neurodegeneration in the substantia nigra and the brain accumulation of Lewy bodies containing α-synuclein protein. In recent decades, however, accumulating research has rev...

Full description

Saved in:
Bibliographic Details
Main Authors: Soo Jung Park, Kyung Won Kim, Eun Jeong Lee
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-12-01
Series:Neural Regeneration Research
Subjects:
Online Access:https://journals.lww.com/10.4103/NRR.NRR-D-24-00994
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086657130561536
author Soo Jung Park
Kyung Won Kim
Eun Jeong Lee
author_facet Soo Jung Park
Kyung Won Kim
Eun Jeong Lee
author_sort Soo Jung Park
collection DOAJ
description Parkinson’s disease has long been considered a disorder that primarily affects the brain, as it is defined by the dopaminergic neurodegeneration in the substantia nigra and the brain accumulation of Lewy bodies containing α-synuclein protein. In recent decades, however, accumulating research has revealed that Parkinson’s disease also involves the gut and uncovered an intimate and important bidirectional link between the brain and the gut, called the “gut–brain axis.” Numerous clinical studies demonstrate that gut dysfunction frequently precedes motor symptoms in Parkinson’s disease patients, with findings including impaired intestinal permeability, heightened inflammation, and distinct gut microbiome profiles and metabolites. Furthermore, α-synuclein deposition has been consistently observed in the gut of Parkinson’s disease patients, suggesting a potential role in disease initiation. Importantly, individuals with vagotomy have a reduced Parkinson’s disease risk. From these observations, researchers have hypothesized that α-synuclein accumulation may initiate in the gut and subsequently propagate to the central dopaminergic neurons through the gut–brain axis, leading to Parkinson’s disease. This review comprehensively examines the gut’s involvement in Parkinson’s disease, focusing on the concept of a gut-origin for the disease. We also examine the interplay between altered gut-related factors and the accumulation of pathological α-synuclein in the gut of Parkinson’s disease patients. Given the accessibility of the gut to both dietary and pharmacological interventions, targeting gut-localized α-synuclein represents a promising avenue for developing effective Parkinson’s disease therapies.
format Article
id doaj-art-72d248716ea24329bc8a8d7123ef6cdf
institution Kabale University
issn 1673-5374
1876-7958
language English
publishDate 2025-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj-art-72d248716ea24329bc8a8d7123ef6cdf2025-02-06T09:58:38ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53741876-79582025-12-0120123416342910.4103/NRR.NRR-D-24-00994Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progressionSoo Jung ParkKyung Won KimEun Jeong LeeParkinson’s disease has long been considered a disorder that primarily affects the brain, as it is defined by the dopaminergic neurodegeneration in the substantia nigra and the brain accumulation of Lewy bodies containing α-synuclein protein. In recent decades, however, accumulating research has revealed that Parkinson’s disease also involves the gut and uncovered an intimate and important bidirectional link between the brain and the gut, called the “gut–brain axis.” Numerous clinical studies demonstrate that gut dysfunction frequently precedes motor symptoms in Parkinson’s disease patients, with findings including impaired intestinal permeability, heightened inflammation, and distinct gut microbiome profiles and metabolites. Furthermore, α-synuclein deposition has been consistently observed in the gut of Parkinson’s disease patients, suggesting a potential role in disease initiation. Importantly, individuals with vagotomy have a reduced Parkinson’s disease risk. From these observations, researchers have hypothesized that α-synuclein accumulation may initiate in the gut and subsequently propagate to the central dopaminergic neurons through the gut–brain axis, leading to Parkinson’s disease. This review comprehensively examines the gut’s involvement in Parkinson’s disease, focusing on the concept of a gut-origin for the disease. We also examine the interplay between altered gut-related factors and the accumulation of pathological α-synuclein in the gut of Parkinson’s disease patients. Given the accessibility of the gut to both dietary and pharmacological interventions, targeting gut-localized α-synuclein represents a promising avenue for developing effective Parkinson’s disease therapies.https://journals.lww.com/10.4103/NRR.NRR-D-24-00994gut inflammationgut microbiomegut–brain axismicro/nano-plasticsparkinson’s diseaseα-synuclein
spellingShingle Soo Jung Park
Kyung Won Kim
Eun Jeong Lee
Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
Neural Regeneration Research
gut inflammation
gut microbiome
gut–brain axis
micro/nano-plastics
parkinson’s disease
α-synuclein
title Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
title_full Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
title_fullStr Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
title_full_unstemmed Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
title_short Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
title_sort gut brain axis and environmental factors in parkinson s disease bidirectional link between disease onset and progression
topic gut inflammation
gut microbiome
gut–brain axis
micro/nano-plastics
parkinson’s disease
α-synuclein
url https://journals.lww.com/10.4103/NRR.NRR-D-24-00994
work_keys_str_mv AT soojungpark gutbrainaxisandenvironmentalfactorsinparkinsonsdiseasebidirectionallinkbetweendiseaseonsetandprogression
AT kyungwonkim gutbrainaxisandenvironmentalfactorsinparkinsonsdiseasebidirectionallinkbetweendiseaseonsetandprogression
AT eunjeonglee gutbrainaxisandenvironmentalfactorsinparkinsonsdiseasebidirectionallinkbetweendiseaseonsetandprogression